Genpharmasec Ltd — Insider Trading, 26-12-2025: Insider Trading / SAST

GENPHARMASEC has closed its trading window, effective January 1st, for promoters, directors, key management, and designated persons. This closure is in compliance with insider trading norms, preventing trading in company securities until 48 hours after the financial results for the quarter ended December 31st are declared. The company will announce the board meeting date to approve these results in due course. This standard procedure ensures fair disclosure and signals the upcoming release of quarterly earnings.